Abstract:LC in cirrhotics is still complicated and highly difficult which associates with significant morbidity compared with that of patients without cirrhosis. However, it offers lower morbidity, shorter operative time; early resume dieting with less need for blood transfusion and reducing hospital stay than OC.
“…CTP class was calculated using prothrombin time, albumin, bilirubin, and clinical findings of ascites and encephalopathy [18]. CTP score was stratified as class A (5-6), B (7-9), and C (10)(11)(12)(13)(14)(15). MELD score was calculated by using preoperative values of three laboratory tests: international normalized ratio (INR), serum total bilirubin (TBil), and serum creatinine (Cr).…”
Section: Methodsmentioning
confidence: 99%
“…prospective randomized trial comparing open cholecystectomy (OC) and LC has been published [11], but more studies are needed in order for solid conclusions to be made.…”
Laparoscopic cholecystectomy can be performed safely in selected patients with cirrhosis Child-Pugh A and B and symptomatic cholelithiasis with acceptable morbidity. Some of its advantages are shorter operative time and reduced hospital stay. MELD score seems to predict morbidity more accurately than Child-Pugh classification system.
“…CTP class was calculated using prothrombin time, albumin, bilirubin, and clinical findings of ascites and encephalopathy [18]. CTP score was stratified as class A (5-6), B (7-9), and C (10)(11)(12)(13)(14)(15). MELD score was calculated by using preoperative values of three laboratory tests: international normalized ratio (INR), serum total bilirubin (TBil), and serum creatinine (Cr).…”
Section: Methodsmentioning
confidence: 99%
“…prospective randomized trial comparing open cholecystectomy (OC) and LC has been published [11], but more studies are needed in order for solid conclusions to be made.…”
Laparoscopic cholecystectomy can be performed safely in selected patients with cirrhosis Child-Pugh A and B and symptomatic cholelithiasis with acceptable morbidity. Some of its advantages are shorter operative time and reduced hospital stay. MELD score seems to predict morbidity more accurately than Child-Pugh classification system.
“…Misidentification of biliary structures is the leading cause of biliary injury and patient related factors may contribute to this error. Although the latter point is controversial, these injuries are more often seen in difficult cases (40)(41)(42)(43)(44)(45)(46)(47)(48). Lack of experience is a risk factor, but injuries may also occur in the hands of experienced surgeons (49,50).…”
Section: Biliary Injury A) What Are the Risk Factors For Bile Duct Inmentioning
Gallstone disease is very common and laparoscopic cholecystectomy is one of the most common surgical procedures all over the world. Parallel to the increase in the number of laparoscopic cholecystectomies, bile duct injuries also increased. The reported incidence of bile duct injuries ranges from 0.3% to 1.4%. Many of the bile duct injuries during laparoscopic cholecystectomy are not due to inexperience, but are the result of basic technical failures and misinterpretations. A working group of expert hepatopancreatobiliary surgeons, an endoscopist, and a specialist of forensic medicine study searched and analyzed the publications on safe cholecystectomy and biliary injuries complicating laparoscopic cholecystectomy under the organization of Turkish Hepatopancreatobiliary Surgery Association. After a series of e-mail communications and two conferences, the expert panel developed consensus statements for safe cholecystectomy, management of biliary injuries and medicolegal issues. The panel concluded that iatrogenic biliary injury is an overwhelming complication of laparoscopic cholecystectomy and an important issue in malpractice claims. Misidentification of the biliary system is the major cause of biliary injuries. To avoid this, the "critical view of safety" technique should be employed in all the cases. If biliary injury is identified intraoperatively, reconstruction should only be performed by experienced hepatobiliary surgeons. In the postoperative period, any deviation from the expected clinical course of recovery should alert the surgeon about the possibility of biliary injury.
“…One study showed that open cholecystectomy for cirrhotic patients had an 11-fold risk of 30-day mortality compared to open cholecystectomy for noncirrhotic patients (13). Mortality after open cholecystectomy in cirrhotic patients varied between 0% and 7.7% (14,15). Most complications and deaths have been related to bleeding from the gallbladder bed , postoperative liver failure, and systemic infection.…”
Scop: De a evalua în spitalul autorilor dacă la pacienţii cu ciroză şi hipertensiune portală cu colelitiază simptomatică tratamentul prin colecistotomie combinată cu Armillarisin A ar aduce noi beneficii. Metode: Şaizeci şi unu de pacienţi cu ciroză şi hipertensiune portală cu boală litiazică veziculară simptomatică trataţi pentru colelitiază fie prin colecistotomie combinată cu Armillarisin A (grupul A), fie prin colecistectomie (grupul B), în perioada februarie 2007 -martie 2011, au fost analizaţi retrospectiv. Aceşti pacienţi erau concomitent trataţi pentru varice esofagice. Au fost analizate datele operatorii relevante, modificările apărute la nivelul analizelor de sânge, complicaţiile postoperatorii şi simptomatologia. Rezultate: Nu au existat diferenţe semnificative între grupul A şi grupul B în ceea ce priveşte durata operaţiei, pierderea intraoperatorie de sânge, timpul până la reluarea dietei postoperator şi durata spitalizării (P > 0.05). Profilul biochimic al funcţiei hepatice şi scorul Child-Pugh la 2 săptămâni şi o lună după operaţie au fost ambele semnificativ mai mici în grupul A comparativ cu grupul B (ALT, 0.008, 0.011; AST, 0.006, 0.003; scorul Child-Pugh, 0.010, respectiv 0.016). Totuşi, la 6 luni postoperator, modificările nu au fost semnificative statistic (P > 0.05). Cu excepţia recurenţei litiazei biliare şi a infecţiilor de plagă, incidentele sau complicaţiile postoperatorii incluzând fistule biliare, insuficienţă hepatică şi infecţia subfrenică au prezentat diferenţe semnificative între cele două
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.